Type 2 Diabetes

Seventeen common biomarkers were differentially expressed in patients with Alzheimer’s Disease or type 2 diabetes when compared with healthy controls. 

According to research presented by Dr. George Bakris of the University of Chicago, treatment with finerenone resulted in a lower risk of the progression of chronic kidney disease and cardiovascular events. 

The SARS-CoV-2 has unfairly affected comorbidities, specifically type 2 diabetes (T2D). A recent study may have the answer as to why this happens. 

By Sheri Colberg, PhD
I recently co-chaired a new consensus statement from the American College of Sports Medicine (ACSM) that is an update from the 2010 joint ACSM/American Diabetes Association position statement on physical activity/exercise for individuals with type 2 diabetes (T2D). A lot more research has been conducted in the ensuing decade since the joint position statement was published, and this new consensus statement summarizes the current evidence.

New study findings reveal the hepatocyte known as follistatin is linked to hyperglycemia when found at elevated levels. 

Diabetes or prediabetes may put a patient at higher risk of developing cardiovascular diseases.

Like medication, exercise can be dosed based on the characteristics of the individual to increase its benefits and reduce side effects, substantially affecting glycemic control. 

A new study reveals that bimagrumab can have metabolic improvement for those suffering from obesity and type 2 diabetes. 

Mitochondrial function is crucial for maintaining cellular metabolism and growth and plays a role in some forms of diabetes. Diabetes mellitus causes much morbidity and mortality for Americans and people worldwide. In addition, it significantly reduces the quality of life and life span of patients that have diabetes. Mitochondrial dysfunction …

Addressing the gaps in lipoprotein cholesterol (LDL-C) control and statin prescribing among patients with type 2 diabetes.